Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 7-14.doi: 10.3736/jcim20100102

• Commentary • Previous Articles     Next Articles

Progress in treatment of chronic heart failure in Western medicine and treatment strategies in traditional Chinese medicine

Chang-xun Chen,Jian-ping Gao, Qi Wu, Juan Guo, Wei-liang Gu   

  1. Department of Pharmacology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2009-09-04 Accepted:2009-10-18 Online:2010-01-20 Published:2010-01-15
  • Contact: Chang-xun Chen

The concept of modern medicine in treating chronic heart failure (CHF) has changed markedly in recent years. To improve the quality of life and prolong life, the treatment goal is no longer just temporary improvement of symptoms, more importantly, is to prevent and delay the occurrence and development of ventricular remodeling. Long-term chronic over-activation of sympathetic system, renin-angiotensin-aldosterone system and other neuroendocrine factors promotes myocardial remodeling, increases myocardial injury and deteriorates cardiac function. Despite short-term use can significantly improve the blood flow dynamics, long-term use of β-adrenergic receptor stimulators and phosphodiesterase inhibitors does not prolong life, but increases the rate of sudden death caused by cardiac arrhythmia. Angiotensin converting enzyme inhibitors and β-blockers have become the preferred drugs in treating chronic heart failure. In fact, after long-term use, β-blockers can significantly improve ventricular remodeling, enhance ventricular function and reduce the incidence of sudden death of patients with CHF. In traditional Chinese medicine practice, short-term use of drugs for warming yang and reinforcing qi can improve symptoms of CHF, but long-term use may have adverse effects, for these medicines can stimulate sympathetic system. Early treatment with medicines of cold and cool property may be more favorable to patients with CHF, except the advanced patients who need special intervention. Eliminating heat and nourishing yin may play more active role in controlling the occurrence and development of CHF. Drugs with good efficacy and value in treating CHF may be developed from the Chinese herbal medicines with eliminating heat and nourishing yin property.

Key words: Chronic heart failure, Ventricular remodeling, Neuroendocrine, Traditional Chinese medicine, Treatment, Drugs,Chinese herbal

[1] Katz AM . Heart failure: a hemodynamic disorder complicated by maladaptive proliferative responses[J]. J Cell Mol Med, 2003,7(1):1-10
doi: 10.1111/j.1582-4934.2003.tb00197.x pmid: 12767256
[2] Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ , DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al.Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group[J]. N Engl J Med, 1991,325(21):1468-1475
doi: 10.1056/NEJM199111213252103
[3] Leier CV . Current status of non-digitalis positive inotropic drugs[J]. Am J Cardiol, 1992,69(18):120G-128G
doi: 10.1016/0002-9149(92)91260-B pmid: 1352656
[4] Kannel WB . Incidence and epidemiology of heart failure[J]. Heart Fail Rev, 2000,5(2):167-173
doi: 10.1023/A:1009884820941 pmid: 16228142
[5] Gu DF, Huang GY, He J, Wu XG, Duan XF . Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2003,31(1):3-6
doi: 10.3760/j:issn:0253-3758.2003.01.002
顾东风, 黄广勇, 何江, 吴锡桂, 段秀芳 . 中国心力衰竭流行病学调查及其患病率[J]. 中华心血管病杂志, 2003,31(1):3-6
doi: 10.3760/j:issn:0253-3758.2003.01.002
[6] Liang QS, Zheng Z . Recent research advances in left ventricular hypertrophy[J]. Xin Xue Guan Bing Xue Jin Zhan, 2001,22(3):143-146
doi: 10.3969/j.issn.1004-3934.2001.03.005
梁黔生, 郑智 . 左室肥厚的研究近况[J]. 心血管病学进展, 2001,22(3):143-146
doi: 10.3969/j.issn.1004-3934.2001.03.005
[7] Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society.ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Soci-ety[J]. Circulation, 2005,112(12):e154-e235
doi: 10.1161/CIRCULATIONAHA.105.553370
[8] Lechat P . Clinical trials of beta-blockers in heart failure: history, overview and future prospects[J]. Therapie, 2004,59(5):517-526
doi: 10.2515/therapie:2004089
[9] Wu XS . The irreplaceable role of beta-blockers in treating heart failure[J]. Zhonghua Lao Nian Duo Qi Guan Ji Bing Za Zhi, 2005,4(4):256-258
doi: 10.3969/j.issn.1671-5403.2005.04.005
吴学思 . β-受体阻滞剂在心力衰竭治疗中不可取代的作用[J]. 中华老年多器官疾病杂志, 2005,4(4):256-258
doi: 10.3969/j.issn.1671-5403.2005.04.005
[10] Ahmed A , Dell'Italia LJ.Use of beta-blockers in older adults with chronic heart failure[J]. Am J Med Sci, 2004,328(2):100-111
doi: 10.1097/00000441-200408000-00006 pmid: 15311169
[11] Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC(HFA) and endorsed by the European Society of Intensive Care Medicine(ESICM)[J]., 2008,29(19):2388-2442
[12] Xian SX, Zhou FJ . Progress of Chinese medicine treatment for heart failure in clinical research[J]. Liaoning Zhong Yi Yao Da Xue Xue Bao, 2006,8(6):165-167
冼绍祥, 周凤娇 . 中医药治疗心力衰竭的临床研究进展[J]. 辽宁中医药大学学报, 2006,8(6):165-167
[13] Zheng XY. Guidelines for clinical research on Chinese new herbal medicines[M]. Beijing: Medical Science and Technology Publishing House of China, 2002: 77
郑筱萸 . 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 77
[14] Wu YT . Treating acute congestive heart failure through phlegm[J]. Hubei Zhong Yi Za Zhi, 2001,23(2):36-37
doi: 10.3969/j.issn.1000-0704.2001.02.036
吴又汀 . 从痰论治急性充血性心力衰竭[J]. 湖北中医杂志, 2001,23(2):36-37
doi: 10.3969/j.issn.1000-0704.2001.02.036
[15] Zhang JW . Experience in treating chronic congestive heart failure through kidney[J]. Shi Jie Zhong Xi Yi Jie He Za Zhi, 2007,2(4):243-244
doi: 10.3969/j.issn.1673-6613.2007.04.022
张建伟 . 从肾论治慢性心衰的体会[J]. 世界中西医结合杂志, 2007,2(4):243-244
doi: 10.3969/j.issn.1673-6613.2007.04.022
[16] Ge HQ, Zhao L, Hao LM . Professor Deng Tietao's experience in treating chronic congestive heart failure through spleen[J]. Shanghai Zhong Yi Yao Za Zhi, 2002,36(4):9-10
doi: 10.3969/j.issn.1007-1334.2002.04.004
葛鸿庆, 赵梁, 郝李敏 . 邓铁涛教授从脾论治慢性充血性心力衰竭之经验[J]. 上海中医药杂志, 2002,36(4):9-10
doi: 10.3969/j.issn.1007-1334.2002.04.004
[17] Wang YS . Treating chronic congestive heart failure through purgation and eliminating water[J]. Hubei Zhong Yi Za Zhi, 2001,23(11):13
doi: 10.3969/j.issn.1000-0704.2001.11.007
王芸素 . 攻下逐水法治疗充血性心力衰竭[J]. 湖北中医杂志, 2001,23(11):13
doi: 10.3969/j.issn.1000-0704.2001.11.007
[18] Li HH . Examples of treating chronic congestive heart failure through directing qi downward[J]. Guangxi Zhong Yi Xue Yuan Xue Bao, 2001,18(1):38-39
李华海 . 降气法治疗充血性心力衰竭举隅[J]. 广西中医学院学报, 2001,18(1):38-39
[19] Zhang W, Zhang LL, Wang SY, Lu WX . Clinical status of obtaining yang from yin in the treatment of heart failure[J]. Liaoning Zhong Yi Za Zhi, 2007,34(4):416-417
doi: 10.3969/j.issn.1000-1719.2007.04.018
张为, 张丽丽, 王声勇, 鲁卫星 . 心衰治疗中阴中求阳的临床地位[J]. 辽宁中医杂志, 2007,34(4):416-417
doi: 10.3969/j.issn.1000-1719.2007.04.018
[20] Katz AM.Potential deleterious effects of inotropic agents in the therapy of chronic heart failure[J].Circulation, 1986, 73(3 Pt 2):III184-III190
[21] He MZ . Effects of large-dose traditional Chinese medicine for tonifying qi to strengthen heart on congestive heart failure[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2000,20(8):630-631
doi: 10.7661/CJIM.2000.8.630
贺明珠 . 大剂量益气强心中药对充血性心力衰竭的影响[J]. 中国中西医结合杂志, 2000,20(8):630-631
doi: 10.7661/CJIM.2000.8.630
[22] Zhang Z . Dialectical treatment by Chinese traditional medicine for the dysfunction of vegetative nervous system[J]. Yunnan Zhong Yi Za Zhi, 1982,( 2):9-12, 49
张震 . 植物神经功能紊乱之辨证论治[J]. 云南中医杂志, 1982,( 2):9-12, 49
[23] Wang DW, Zhao HY . Research on autonomic nervous system and cardiovascular diseases[J]. Xin Xue Guan Bing Xue Jin Zhan, 1995,16(5):257-260
汪道文, 赵华月 . 植物神经系统与心血管疾病的研究进展[J]. 心血管病学进展, 1995,16(5):257-260
[24] Ferrari R, Ceconi C, Curello S, Visioli O . The neuroendocrine and sympathetic nervous system in congestive heart failure[J]. Eur Heart J, 1998,19(Suppl F):F45-F51
doi: 10.1053/euhj.1997.0856 pmid: 9651735
[25] Kannel WB . Incidence and epidemiology of heart failure[J]. Heart Fail Rev, 2000,5(2):167-173
doi: 10.1023/A:1009884820941 pmid: 16228142
[26] Zhao C, Ye Y, Wu Y, Xie YH . Modern treatment of chronic heart failure and ideas of TCM diagnosis and treatment of the disease[J]. Zhongguo Zhong Yi Ji Zheng, 2006,15(2):l58-159, 163
doi: 10.3969/j.issn.1004-745X.2006.02.031
赵淳, 叶勇, 吴英, 谢郁华 . 慢性心力衰竭现代治疗进展及中医诊治思路探讨[J]. 中国中医急症, 2006,15(2):l58-159, 163
doi: 10.3969/j.issn.1004-745X.2006.02.031
[27] Wu Q, Chen CX, Gu WL, Gao JP . Influence of wild chrysanthemum on some neuroendocrine factors in ventricular remodeling induced by abdominal aortic banding in rats[J]. Zhonghua Zhong Yi Yao Za Zhi, 2009,24(9):1140-1143
吴琦, 陈长勋, 顾伟梁, 高建平 . 野菊花对压力负荷性大鼠左室心肌及神经内分泌因子的影响[J]. 中华中医药杂志, 2009,24(9):1140-1143
[28] Han XD, Chen CX . Effect of matrine on ventricular remodeling in mice treated with isoprenaline[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2007,13(7):509-512
doi: 10.3969/j.issn.1006-3250.2007.07.011
韩向东, 陈长勋 . 苦参碱对异丙肾上腺素致小鼠心室重构的影响[J]. 中国中医基础医学杂志, 2007,13(7):509-512
doi: 10.3969/j.issn.1006-3250.2007.07.011
[29] Chen CX, Wang Y . Comparative study of herbs of Yuxingcao, Paojiang and Fuzi on ventricular remodeling induced by high pressure in rats[J]. Zhong Cheng Yao, 2009,31(1):24-30
陈长勋, 王樱 . 鱼腥草、炮姜、 附子抗大鼠压力超负荷心室重构作用的比较研究[J]. 中成药, 2009,31(1):24-30
[30] Gao JP, Chen CX, Wang Y, Lu J, Gu WL . Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats[J]. J Pharm Pharmacol, 2009,61(5):677-683
doi: 10.1211/jpp.61.05.0018 pmid: 19406008
[31] Gu WL, Chen CX, Wang Y . The influence of Xuan-shen on the concentration of AngⅡ and the expression of ATlA mRNA in ventricular remodeling rats[J]. Shi Zhen Guo Yi Guo Yao, 2008,19(7):1547-1549
doi: 10.3969/j.issn.1008-0805.2008.07.001
顾伟梁, 陈长勋, 王樱 . 玄参对心室重构大鼠血管紧张素Ⅱ及其1型受体基因表达的影响[J]. 时珍国医国药, 2008,19(7):1547-1549
doi: 10.3969/j.issn.1008-0805.2008.07.001
[32] Gu WL, Chen CX, Wang Y . Comparative study of Scrophulariae and Aconite in inhibiting myocardial hypertrophy in rats and mice[J]. J Chin Integr Med, 2008,6(4):376-380
顾伟梁, 陈长勋, 王樱 . 玄参和附子抗鼠心肌肥厚作用的对比实验研究[J]. 中西医结合学报, 2008,6(4):376-380
[33] Guo J, Chen CX . Influence of Tinglizi on some neuroendocrine factors and type Ⅰ and Ⅲ collagen in ventri-cular remodeling induced by abdominal aortic banding in rats[J]. Zhong Yao Cai, 2007,30(8):963-967
郭娟, 陈长勋 . 葶苈子对压力负荷性大鼠心室重构及神经内分泌因子和心肌Ⅰ、Ⅲ型胶原的影响[J]. 中药材, 2007,30(8):963-967
[34] Guo J, Chen CX, Shen YH . Effect of aqueous extract from Semen Lepidii seu Descurainiae on ventricular remodeling in experimental animals[J]. Zhong Cao Yao, 2007,38(10):1519-1523
doi: 10.3321/j.issn:0253-2670.2007.10.029
郭娟, 陈长勋, 沈云辉 . 葶苈子水提液对动物实验性心室重构的影响[J]. 中草药, 2007,38(10):1519-1523
doi: 10.3321/j.issn:0253-2670.2007.10.029
[35] Guo J, Chen CX, Du J, Gu WL, Shen YH . Semen Desurainiae inhibits CYP11B1, CYP11B2 and TGF-β1 mRNA expression in left ventricular[J]. Zhong Yao Cai, 2008,31(11):1691-1695
doi: 10.3321/j.issn:1001-4454.2008.11.031
郭娟, 陈长勋, 杜军, 顾伟梁, 沈云辉 . 葶苈子对压力负荷大鼠心肌CYP11B1、CYP11B2及TGF-β1 mRNA表达的影响[J]. 中药材, 2008,31(11):1691-1695
doi: 10.3321/j.issn:1001-4454.2008.11.031
[36] Murphy E.Eisner DA . How does endothelin-1 cause a sustained increase in intracellular sodium and calcium which lead to hypertrophy[J]. J Mol Cell Cardiol, 2006,41(5):782-784
doi: 10.1016/j.yjmcc.2006.08.003
[37] Murray DB, Gardner JD, Brower GL, Janicki JS . Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats[J]. Am J Physiol Heart Circ Physiol, 2004,287(5):H2295-H2299
doi: 10.1152/ajpheart.00048.2004
[38] Sivasubramanian N, Coker ML, Kurrelmeyer KM , MacLellan WR, DeMayo FJ, Spinale FG, Mann DL.Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor[J]. Circulation, 2001,104(7):826-831
doi: 10.1161/hc3401.093154
[39] Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG . Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective[J]. Cardiovasc Res, 2002,53(4):822-830
doi: 10.1016/S0008-6363(01)00503-X
[40] Bujak M, Frangogiannis NG . The role of TGF-beta signaling in myocardial infarction and cardiac remodeling[J]. Cardiovasc Res, 2007,74(2):184-195
doi: 10.1016/j.cardiores.2006.10.002 pmid: 1924687
[41] Wang Y, Chen CX, Du J, Gu WL, Lu J . Comparative study of Zengye decoction and Sini decoction on inhibiting ventricular remodeling[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2008,14(5):58-62
王樱, 陈长勋, 杜军, 顾伟梁, 吕见 . 增液汤和四逆汤抗心室重构的比较研究[J]. 中国实验方剂学杂志, 2008,14(5):58-62
[42] Du J, Chen CX, Wang Y, Ha MLT, Xu YC . Experimental research of Jiajian Yunu Decoction on ventricular remodeling[J]. Zhong Cheng Yao, 2008,30(1):24-27
doi: 10.3969/j.issn.1001-1528.2008.01.008
杜军, 陈长勋, 王樱, 哈木拉提, 徐祎春 . 加减玉女煎抗心室重构的实验研究[J]. 中成药, 2008,30(1):24-27
doi: 10.3969/j.issn.1001-1528.2008.01.008
[43] Du J, Chen CX, Wang Y, Ha MLT, Xu YC . Effects of Jiajianyunujian on hemodynamics and RAS in rats with ventricular remodeling[J]. Zhonghua Shi Yong Zhong Xi Yi Za Zhi, 2007,20(21):1841-1843, 1845
杜军, 陈长勋, 王樱, 哈木拉提, 徐祎春 . 加减玉女煎对心室重构大鼠血流动力学和RAS的干预作用[J]. 中华实用中西医杂志, 2007,20(21):1841-1843, 1845
[44] Liang YH . Progress in the study of the nature of cold and heat syndromes[J]. Zhong Yi Za Zhi, 1988,2:63-65
梁月华 . 寒热本质研究的进展[J]. 中医杂志, 1988,2:63-65
[45] Liang YH, Wang CS, Zhang YJ . A research of the mechanism and effect of cold and hot compound prescription and Rhizoma Anemarrhenae on sympathetic nervous system[J]. Zhongguo Zhong Yao Za Zhi, 1988,13(11):48-50
梁月华, 王传社, 章云津 . 寒凉和温热药复方及知母对交感神经系统的作用与机制探讨[J]. 中国中药杂志, 1988,13(11):48-50
[46] Song H, Liang YH . The effect of yang-warming and qi-tonifying natural products on neuroendocrine of deficiency-cold rats[J]. Zhongguo Zhong Yao Za Zhi, 1997,22(3):182-184
doi: 10.1007/BF02951625
宋辉, 梁月华 . 温阳和补气药对虚寒证大鼠神经内分泌的影响[J]. 中国中药杂志, 1997,22(3):182-184
doi: 10.1007/BF02951625
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[4] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Ye-juan Jia, Tian-yu Li, Peng Han, Yu Chen, Li-jia Pan, Chun-sheng Jia. Effects of different courses of moxibustion treatment on intestinal flora and inflammation of a rat model of knee osteoarthritis. Journal of Integrative Medicine, 2022, 20(2): 173-181.
[7] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[8] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[9] Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[10] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11] Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299.
[12] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[13] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
[14] Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202.
[15] Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228